-
FDA/CBER - BK080060 LCG2 Leukoreduction System for AS-1, AS-3, and AS-5 Red Blood Cells
AS-1  AS-3  bk080060  LCG2  Leukoreduction System 
nl18070.celltherapynews.com - 2009-03-07
-
CBER Exceptions and Alternative Procedures Approved Under 21 CFR 640.120
21 CFR 640.120  alternative procedures 
nl18072.celltherapynews.com - 2009-03-07
-
Superlative BioSciences Corporation - Striving to be the Leader in Customized Animal and Plant Cell Culture Services. Contact info@superlativebio.com for ...
animal cell culture  animal product free  animal product-free  Master Batch Records  product pathways 
www.superlativebio.com - 2009-02-03
-
FDA/CBER - BK080004 Clotalyst and GPS III Platelet Concentrate Separation Kit with ACD-A and Clotalyst and GPS III Mini Platelet Concentrate Separation Kit with ...
bk080004  Clotalyst  Concentrate Separation Kit  GPS III 
nl18071.celltherapynews.com - 2009-03-07
-
CBER 2008 Biological License Application Approval
nl18160.celltherapynews.com - 2009-03-07
-
CBER 2008 Biological Device Application Approvals
nl18159.celltherapynews.com - 2009-03-07
-
The RegSource Regulatory page is a comprehensive site to information resources for the pharmaceutical professionals. The site provides links to regulatory and ...
Goodlaboratory Practice 
www.regsource.com - 2009-02-07
-
CBER - 2008 Biological License Application Supplement Approvals
nl18161.celltherapynews.com - 2009-03-07
-
Pass your FDA inspection! Pharmaceuticals, Medical Devices, Biotechnology, Biopharmaceuticals, Food, Nutraceuticals, Dietary Supplements, FDA consulting, ...
www.fdainspection.com - 2009-02-04
-
The Centre for Biodiversity and Ecology Research combines world class research in terrestrial and aquatic ecology, animal behaviour behavior, molecular ecology, ...
cber.bio.waikato.ac.nz - 2009-04-11
|
cder
drug
biologics
gmp
biotechnology
medical device
fda
pharmaceutical
|
|